Tag archive for ‘Biogen Tecfidera’
Shiri Habib-Valdhorn On Sunday, August 24th, 2014

New Biogen MS drug challenges Copaxone

– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. –   Changes in the multiple sclerosis treatment market, in which Israeli pharmaceutical firm More...

Wordpress site Developed by Fixing WordPress Problems